1.Efficacy and Safety of Plerixafor Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Lymphoma Patients.
Fang-Shu GUAN ; Dong-Hua HE ; Yi LI ; Yi ZHANG ; Gao-Feng ZHENG ; Yuan-Yuan ZHU ; Jing-Song HE ; En-Fan ZHANG ; Zhen CAI ; Yi ZHAO
Journal of Experimental Hematology 2023;31(4):1056-1060
OBJECTIVE:
To investigate the efficacy and safety of plerixafor combined with granulocyte colony-stimulating factor (G-CSF) in mobilizing peripheral blood hematopoietic stem cells in patients with lymphoma.
METHODS:
The clinical data of lymphoma patients who received autologous hematopoietic stem cell mobilization using plerixafor combined with G-CSF from January 2019 to December 2021 were retrospectively analyzed. The patients received 3 kinds of mobilization regimens: front-line steady-state mobilization, preemptive intervention, and recuse mobilization. The acquisition success rate, excellent rate of collection, and incidence of treatment-related adverse reaction were counted. The influence of sex, age, disease remission status, bone marrow involvement at diagnosis, chemotherapy lines, number of chemotherapy, platelet count and number of CD34+ cells on the day before acquisition in peripheral blood on the collection results were analyzed to identify the risk factors associated with poor stem cell collection.
RESULTS:
A total of 43 patients with lymphoma were enrolled, including 7 cases who received front-line steady-state mobilization, 19 cases who received preemptive intervention, and 17 cases who received recuse mobilization. The overall acquisition success rate was 58.1% (25/43) after use of plerixafor combined with G-CSF, and acquisition success rate of front-line steady-state mobilization, preemptive intervention, and recuse mobilization was 100%, 57.9%(11/19), and 41.2%(7/17), respectively. The excellent rate of collection was 18.6%(8/43). A total of 15 patients experienced mild to moderate treatment-related adverse reactions. The number of CD34+ cells < 5 cells/μl in peripheral blood on the day before collection was an independent risk factor affecting stem cell collection.
CONCLUSIONS
Plerixafor combined with G-CSF is a safe and effective mobilization regimen for patients with lymphoma. The number of CD34+ cells in peripheral blood on the day before collection is an predictable index for the evaluation of stem cell collection.
Humans
;
Antigens, CD34/metabolism*
;
Granulocyte Colony-Stimulating Factor/therapeutic use*
;
Hematopoietic Stem Cell Mobilization/methods*
;
Hematopoietic Stem Cell Transplantation
;
Heterocyclic Compounds/therapeutic use*
;
Lymphoma/drug therapy*
;
Multiple Myeloma/drug therapy*
;
Retrospective Studies
;
Transplantation, Autologous
2.Clinical observation of performing rhegmatogenous retinal detachment surgery under operation microscope
Zhi-Xin, SHEN ; En-Fang, GAO ; Wen-Qing, WENG
International Eye Science 2015;(2):339-341
To compare the effect and advantage of performing rhegmatogenous retina detachment surgery under operation microscope with under direct ophthalmoscopes .METHODS: Ninety - three patients ( 93 eyes ) were randomized to two groups, Group A ( under operation microscope during rhegmatogenous retina detachment surgery, 47 cases ) , Group B ( under direct ophthalmoscopes during rhegmatogenous retina detachment surgery, 46 cases ) . All patients were followed up for 2wk to observe success rate and visual improving rate.RESULTS: Total percentage of success was 95. 74% in group A and 80. 43% in group B. The visual improving rate of group A was 82. 98% and it was 67. 39% in group B. Operative time in group A was significantly shorter than that in group B (P<0. 05). CONCLUSlON: Performing rhegmatogenous retina detachment surgery under operation microscope is ascertaining and it is more effective and handy than performing that surgery under direct ophthalmoscopes.
3.Tortuosity and kinking of cervical segment of internal carotid artery: an analysis of 7 cases
Tie-Chuan CONG ; Xing DUAN ; Wei-Hua GAO ; En-Min ZHAO ; Xue-Dong YANG ; He WANG ; Shui-Fang XIAO ; Yong QIN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2012;47(11):913-917
Objective To introduce the clinical manifestations and compare the different radiological methods of detecting the malformation of cervical segment of internal carotid artery.Methods A retrospective analysis of 7 cases with malformation of cervical segment of internal carotid artery between May,2004 and April,2011 was conducted.CT angiography (CTA) and magnetic resonance angiography (MRA) were used to detect the morphology of cervical segment of internal carotid artery.Results This disease entity provided no obvious symptoms in five cases,and only such complaints as pharyngeal foreign body sensation in one and odynophagia in another were described.Physical examination showed a bulge with pulsation on pharyngeal wall in four cases,and apparent normal pharynges in other three patients,all of which were covered with intact pharyngeal mucosa.Twelve carotid arteries in seven cases were observed,five of which showed tortuosities and seven kinkings.All of the five patients with recorded radiological examination had identified malformations of internal carotid artery,two of which were tortuosities bilaterally and two kinkinks bilaterally and one tortuosity and kinking respectively.CTA and MRA revealed tortuosities of cervical segment of internal carotid arteries.Conclusions No typical clinical symptoms were found in the malformation of cervical segment of internal carotid artery.Pharyngeal bulge with pulsation could be encountered.CTA and MRA showed excellent ability to depict the malformation of cervical segment of internal carotid artery and its relationship with surrounding structures,which could protect carotid artery from unintended damage.
4.A comparative study of complications in transoral CO2 and Nd: YAG laser surgery for glottic carcinoma
Yun-Jun GAO ; Shui-Fang XIAO ; Quan-Gui WANG ; Yong QIN ; En-Min ZHAO ; Hong SHEN ; Tian-Cheng LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2011;46(8):658-663
Objective To compare the complications in transoral CO2 and Nd: YAG laser surgery for the treatment of laryngeal carcinoma. Methods Retrospective analysis of 83 cases of glottic laryngeal carcinoma treated with laser surgery from January 1,1999 to December 31,2008 was carried out. Thirty-two cases were treated with the CO2 laser, including Tis(2 cases), T1N0M0 (21 cases), T2N0M0 (8 cases),and T3N0M0 (1 case). Fifty-one cases were treated with the Nd:YAG laser, including Tis (3 cases),T1N0M0 (36 cases), T1N2M0 (3 cases), and T2N0M0 (9 cases). Results Four complications ( 12.5% )occurred in the CO2 laser group. There was 1 local infection ( 3.1% ), 1 numbness of the tongue ( 3.1% ),1 odontoseisis (3. 1 % ), and 1 subcutaneous emphysema (3.1% ). Twenty-seven complications (52.9%)occurred in 19 patients in the Nd: YAG laser group. There were postoperative bleeding 2(3.9% ), dyspnea 5 ( 9. 8% ), local infection 7 ( 13.7% ), aspiration pneumonia 4 ( 7. 8% ), numbness of the tongue 2(3. 9% ), pharyngeal cutaneous fistula 1 (2.0%), vocal cord fixation 4 (7.8%), and laryngostenosis 2(3.9% ). Conclusion More complications were observed in the patients with Nd: YAG laser surgery when compared to the patients with CO2 laser surgery.
5.A study on seroprevalence of anti-HAV IgG in adults of 4 cities in China.
Yuan-yuan CHENG ; Jing-jing NIE ; Jie LI ; Jin-lin HOU ; Xin-xin ZHANG ; Qing NING ; Xiu-yuan GAO ; Hong-fang DING ; Xue-en LIU ; Hui ZHUANG
Chinese Journal of Hepatology 2009;17(12):896-899
OBJECTIVETo investigate the seroprevalence of anti-HAV IgG in adults of 4 cities in China.
METHODSSerum samples were collected from 2390 local residents aged between 20 to 88 years from Beijing, Shanghai, Wuhan and Guangzhou. The anti-HAV IgG in sera was detected with a microparticle enzyme immunoassay (MEIA).
RESULTSThe anti-HAV IgG seroprevalence in female of 30 to 39 years in Beijing (64.58%, 62/96) was higher than that in male (45.57% 36/79)) (x(2) = 6.358, P = 0.012). It increased with age in adults of Beijing and Guangzhou. The rates were 54.22 % (90/166), 56.00% (98/175) and 67.18% (88/131) for the 20-, 30- and 40-49 age groups in Beijing (x(2) = 4.76, P = 0.03); and 52.83% (56/106), 52.50% (63/120), 82.46% (94/114), 89.80% (88/98) and 96.77% (60/62) for the 20-, 30-, 40-, 50- and 60-88 age groups in Guangzhou, respectively (x(2) = 72.58, P less than 0.01). This trend was not found in Shanghai and Wuhan (x2 = 0.96, 2.99; P = 0.33, 0.08 respectively). The seroprevalence rates of anti-HAV IgG in the 20 to 39 age group of Beijing, Shanghai, Guangzhou and Wuhan were 55.13% (188/341), 63.93% (429/671), 52.65% (119/226) and 78.37% (308/393), respectively.
CONCLUSIONThe seroprevalence rates of anti-HAV IgG in young adults aged 20 to 39 years of the four cities are relatively low, and HAV vaccination should be suggested for the susceptible population of this age group in China.
Adult ; Age Distribution ; Aged ; Aged, 80 and over ; China ; epidemiology ; Female ; Hepatitis A ; epidemiology ; immunology ; prevention & control ; Hepatitis A Antibodies ; blood ; Hepatitis A Virus, Human ; immunology ; Humans ; Immunoglobulin G ; blood ; Male ; Middle Aged ; Seroepidemiologic Studies ; Sex Distribution ; Urban Population ; Young Adult
6.Preparation and identification of monoclonal antibody against enoyl-CoA hydratase 1.
Yan-fang JU ; Rong LIU ; Xiao-lan LIU ; Jin-ju YANG ; Jian-en GAO ; Qi-hong SUN
Journal of Southern Medical University 2009;29(4):648-651
OBJECTIVETo prepare monoclonal antibodies (mAbs) against enoyl-CoA hydratase 1 (ECH1).
METHODSNormal human liver tissues were homogenized, and the mitochondria were isolated by differential centrifugation. The total mitochondrial proteins were used to immunize BALB/c mice to prepare mAbs by routine hybridoma technique. The mAbs were characterized by ELISA, Western blotting and immunohistochemistry. The specificity of the antibody was identified by mass spectrometry (MS) following immunoprecipitation (IP) and confirmed by Uni-ZAP expression library screening.
RESULTSOne clone of the hybridoma BGB095 secreting specific mAb against ECH1 was obtained. The mAb was identified to belong to Ig subclass IgG1 and could be used in ELISA, Western blotting, immunohistochemistry, and immunoprecipitation.
CONCLUSIONA hybridoma cell line stably secreting specific mAb against ECH1 has been established. The specific mAb against ECH1 can be of great value for functional and distribution studies of ECH1.
Animals ; Antibodies, Monoclonal ; analysis ; immunology ; Antibody Specificity ; Blotting, Western ; Cell Line ; Enoyl-CoA Hydratase ; immunology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunohistochemistry ; Liver ; cytology ; metabolism ; Mice ; Mice, Inbred BALB C ; Mitochondria ; metabolism
7.N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
Xue-en LIU ; Liesbeth DESMYTER ; Chun-fang GAO ; Wouter LAROY ; Sylviane DEWAELE ; Valerie VANHOOREN ; Ling WANG ; Hui ZHUANG ; Nico CALLEWAERT ; Claude LIBERT ; Roland CONTRERAS ; Cui-ying CHEN
Chinese Journal of Hepatology 2008;16(1):74-75
8.Construction and expression of RU486-inducible eukaryotic vector carrying red fluorescent protein.
Jian CHEN ; Xu-chao XUE ; Gao-en FANG ; Chang-qing SU ; Qi-jun QIAN
Journal of Southern Medical University 2008;28(12):2113-2116
OBJECTIVETo construct an inducible eukaryotic vector carrying red fluorescent protein (DsRed) and evaluate the regulation of DsRed gene expression in vitro.
METHODSThe vector pRS17-RUDsRed containing DsRed gene, promoter and RU486-inducible system was constructed using molecular biological methods. To minimize potential interference, the two transcriptional elements were spaced with a 1.6 kb insulator. Fluorescence microscopy and flow cytometry were used to observe the activation of this regulatable vector after transfection in MFC cells.
RESULTSThe vector was identified by digestion with different restriction enzymes, sequencing and PCR. In the absence of RU486, the cells transfected with the vector exhibited very low DsRed protein expression, and the addition of RU486 induced efficient DsRed expression in the cells.
CONCLUSIONThe RU486-inducible eukaryotic vector carrying DsRed protein allows effective regulation of the target gene expression in vitro, which provides a useful tool for gene regulation and gene therapy studies.
Gene Expression Regulation ; Genetic Therapy ; methods ; Genetic Vectors ; genetics ; Humans ; Luminescent Proteins ; genetics ; metabolism ; Mifepristone ; pharmacology ; Promoter Regions, Genetic ; genetics ; Stomach Neoplasms ; genetics ; pathology ; Tumor Cells, Cultured
9.Clinical efficacy of rapid Rhino Stammberger sinus dressing following endoscopic sinus surgery
Hong SHEN ; Shui-Fang XIAO ; Tian-Cheng LI ; En-Min ZHAO ; Jun WANG ; Wei-Hua GAO
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2008;43(10):782-785
Objective To compare the clinical benefits of rapid Rhino Stammberger sinus dressing (RR), a new nasal packing material for functional endoscopic sinus surgery (ESS), with traditional packing materials sorbalgon plus Vaseline gauze (SV) prospectively. Methods Twenty-four patients with chronic sinusitis of the similar grade were enrolled in the study. After ESS, the nasal cavities of each patient were packed with RR in the right side as observing group and SV in the left side as control group. SV in the left nasal cavity was removed in the first day after operation and RR remained in the right nasal cavity until the first endoscopic follow-up 1 week postoperatively. The same perioperative treatments such as irrigation and local steroid were given in both sides of nasal cavities. The grade of rhinalgia, nasal obstruction, discharge, bleeding and epiphora in each side of nasal cavities were assessed on a visual analogue scale (VAS) by the patients at the operation day (packing period), the first day and the second day after operation respectively. Postoperative endoscopic assessment of nasal cavities including crest, discharge, pseudomembrane, edema of mucosa, bubble and ostium obstruction were carried out by a rhinologist on VAS at 1, 2, 3, 4, 6, 8 weeks postoperatively. The follow-up continued until the complete mucosal healing. Results Three patients were dropped from statistical analysis. One of them with severe hypertension bleeding when he awoke from anesthesia, the RR was run out from the nasal cavity. The other two were lost in the follow-up. Twenty-one patients completed the follow -up ranging between 2 - 20 months. The scores of rhinalgia, epiphora at the operation day and the rhinalgia at the first day after operation in RR side were lower than SV side ( P < 0. 05). The scores of the amount of crust at the first week after operation in RR side were lower than SV side (P < 0. 05). Statistically, no significant deference was found between RR and SV in the length of mucosal healing period. Conclusious Patients felt more comfortable with the package of RR than traditional material No pain and secondary bleeding happened. The efficacy of RR on mucosal healing was similar with SV. RR showed some advantages and could be used as packing material following ESS.
10.Preparation and identification of monoclonal antibody against UGP2.
Wan WANG ; Yuan GAO ; Jin-Ju YANG ; Xiao-Lan LIU ; Yan-Fang JU ; Li LIU ; Zhi-Cheng CHEN ; Rong LIU ; Jun CHI ; Wei-Xian XING ; Jian-En GAO ; Li-Guo AN ; Qi-Hong SUN
Journal of Experimental Hematology 2007;15(3):563-566
The study was aimed to generate monoclonal antibodies (mAbs) against homo sapiens UDP-glucose pyrophosphorylase 2 (UGP2). Normal human liver tissues homogenized, and cytosolic proteins isolated by centrifugation were used to immunize BALB/c mice to generate mAbs by hybridoma technique. The mAbs were identified by ELISA, Western blot, and immunohistochemistry assay. The antibody specificity was confirmed by Uni-ZAP expression library screening. The results indicated that one hybridoma BAD062 secreting specific mAb against UGP2 was established. The Ig subclass of this mAb was IgG(2b) (kappa), and it could be used in ELISA, Western blot, immunohistochemistry assay. The antigen recognized by BAD062 mAb was localized in the hepatocyte cytoplasm, with molecular weight of 56 kD in the cytosolic proteins of human liver tissue. The BAD062 mAb was further confirmed by immunoscreening of Uni-ZAP XR liver cDNA expression library. It is concluded that a hybridoma cell line stably secretes specific mAb against UGP2. This mAb reacted with UGP2 in ELISA, Western blot, immunohistochemistry assay, and would be very useful for the UGP2 studies.
Animals
;
Antibodies, Monoclonal
;
analysis
;
biosynthesis
;
Antibody Specificity
;
Base Sequence
;
Humans
;
Hybridomas
;
secretion
;
Liver
;
metabolism
;
Mice
;
Mice, Inbred BALB C
;
Molecular Sequence Data
;
UTP-Glucose-1-Phosphate Uridylyltransferase
;
immunology

Result Analysis
Print
Save
E-mail